KSE - Delayed Quote KRW

ORIENT BIO Inc. (002630.KS)

1,179.00
-109.00
(-8.46%)
At close: May 30 at 3:30:05 PM GMT+9

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.
NameTitlePayExercisedYear Born
Mr. Jae-Jin Chang Chairperson, President & CEO -- -- 1961
Mr. Tae-Seok Han Managing Director of Sales -- -- 1977

ORIENT BIO Inc.

322, Galmachi-ro
Jungwon-gu
Seongnam-si
South Korea
82 3 1730 6100 https://www.orient.co.kr
Sector: 
Healthcare
Industry: 
Biotechnology

Description

ORIENT BIO Inc. operates in the bio-industry in South Korea. It produces laboratory animals; and offers various equipment for research environment. The company was formerly known as Orient Co., Ltd. and changed its name to ORIENT BIO Inc. in 2005. ORIENT BIO Inc. was founded in 1959 and is based in Seongnam-si, South Korea.

Corporate Governance

ORIENT BIO Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers